The FDA announced on April 16, 2026, that American Regent, Inc. is recalling Levocarnitine Injection, USP due to missing labeling. The recall affects 74,040 single-dose vials distributed nationwide.
How to tell if you have it
- Brand: American Regent
- Product: Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial
- NDC: 0517-1045-01
- Lot 24159N0C0, Exp. June 30, 2026
- Lot 25193N0C0, Exp. July 31, 2027
The hazard
The hazard is missing labeling on the product. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show American Regent, Inc. has 6 other recalls on record since May 13, 2024. Recent recalls include an August 11, 2026 epinephrine injection recall for particulate matter risk and a July 24, 2026 cyanocobalamin injection recall for particulate matter hazards. Other recent recalls of similar products include an August 19, 2026 American Health Packaging Buprenorphine Tablets recall for label mix-up hazard, a April 1, 2026 Wells Pharma Fentanyl Citrate Injectable Solution recall for CGMP deviations, and a March 17, 2026 Nephron Albuterol Inhaler recall for illegible label hazard.